Blier P, de Montigny C, Chaput Y
Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
Clin Neuropharmacol. 1988;11 Suppl 2:S1-10.
The efficacy of serotoninergic (5-HT) neurotransmission was assessed in the rat brain following different types of antidepressant treatments. First, the firing rate of 5-HT neurons was assessed. Second, the responsiveness of postsynaptic neurons to 5-HT was evaluated by applying directly onto these neurons the neurotransmitter by microiontophoresis. Finally, the effect of the electrical stimulation of the 5-HT pathway on the firing activity of the same postsynaptic neurons was studied in order to determine the efficacy of synaptic transmission. Long-term administration of tricyclic antidepressant drugs induces a sensitization of rat forebrain neurons to 5-HT without altering 5-HT neuron properties. This sensitization results in an enhancement of the effect of the stimulation of the 5-HT pathway on the firing activity of postsynaptic neurons. Long-term administration of antidepressant monoamine oxidase inhibitors also results in an enhancement of the effectiveness of the stimulation of the 5-HT pathway. This is not due to a modification of postsynaptic neuron properties, since there is no enhancement of their responsiveness to 5-HT. Furthermore, the function of the terminal 5-HT autoreceptor is not altered by long-term treatment with a monoamine oxidase inhibitor. Therefore, the enhancement of 5-HT neurotransmission produced by this type of drugs is due to an increased availability of releasable 5-HT. The acute administration of 5-HT reuptake blockers does not enhance the efficacy of the stimulation of the 5-HT pathway. However, their long-term administration produces such an enhancement without altering the responsiveness of postsynaptic neurons to 5-HT. This modification of 5-HT transmission is attributable to a desensitization of the terminal 5-HT autoreceptor, thereby allowing a greater amount of 5-HT to be released per impulse in the synaptic cleft. The electrophysiological assessment of the effects of these different types of antidepressant treatments on the 5-HT system therefore revealed as a common effect an enhancement of 5-HT neurotransmission, albeit each one achieving this via a different mechanism.
在给予不同类型抗抑郁药物治疗后,对大鼠脑内5-羟色胺能(5-HT)神经传递的功效进行了评估。首先,评估5-HT神经元的放电频率。其次,通过微离子电泳法将神经递质直接施加于突触后神经元,以此来评估其对5-HT的反应性。最后,研究5-HT通路的电刺激对相同突触后神经元放电活动的影响,以确定突触传递的功效。长期给予三环类抗抑郁药物会使大鼠前脑神经元对5-HT产生敏化作用,而不会改变5-HT神经元的特性。这种敏化作用导致5-HT通路刺激对突触后神经元放电活动的影响增强。长期给予抗抑郁单胺氧化酶抑制剂也会使5-HT通路刺激的有效性增强。这并非是由于突触后神经元特性的改变,因为它们对5-HT的反应性并未增强。此外,单胺氧化酶抑制剂的长期治疗不会改变终末5-HT自身受体的功能。因此,这类药物所产生的5-HT神经传递增强是由于可释放的5-HT可用性增加。5-HT再摄取阻滞剂的急性给药不会增强5-HT通路刺激的功效。然而,它们的长期给药会产生这种增强作用,且不会改变突触后神经元对5-HT的反应性。5-HT传递的这种改变归因于终末5-HT自身受体的脱敏,从而使得每个突触前冲动在突触间隙释放更多的5-HT。因此,对这些不同类型抗抑郁治疗对5-HT系统影响的电生理评估揭示出一个共同的效应,即5-HT神经传递增强,尽管每种治疗都是通过不同的机制实现这一点。